» Articles » PMID: 36183999

TGF-β in Developmental and Fibrogenic EMTs

Overview
Specialty Oncology
Date 2022 Oct 2
PMID 36183999
Authors
Affiliations
Soon will be listed here.
Abstract

TGF-β plays a prominent role as an inducer of epithelial-mesenchymal transitions (EMTs) during development and wound healing and in disease conditions such as fibrosis and cancer. During these processes EMT occurs together with changes in cell proliferation, differentiation, communication, and extracellular matrix remodeling that are orchestrated by multiple signaling inputs besides TGF-β. Chief among these inputs is RAS-MAPK signaling, which is frequently required for EMT induction by TGF-β. Recent work elucidated the molecular basis for the cooperation between the TGF-β-SMAD and RAS-MAPK pathways in the induction of EMT in embryonic, adult and carcinoma epithelial cells. These studies also provided direct mechanistic links between EMT and progenitor cell differentiation during gastrulation or intra-tumoral fibrosis during cancer metastasis. These insights illuminate the nature of TGF-β driven EMTs as part of broader processes during development, fibrogenesis and metastasis.

Citing Articles

Chitosan-Artesunate nanoparticles: A dual anti-fibrotic and anti-inflammatory strategy for preventing bleb fibrosis post-glaucoma filtration surgery.

Liu J, Wang S, Tan G, Tong B, Wu Y, Zhang L Drug Deliv Transl Res. 2025; .

PMID: 40019651 DOI: 10.1007/s13346-025-01819-7.


CC-chemokine ligand 18, CXC motif chemokine 13 and osteopontin as biomarkers of silicosis and asbestosis: a prospective observational study.

Wu N, Xue C, Yu S, Wang Y, Sun D, Ye Q Sci Rep. 2025; 15(1):6819.

PMID: 40000810 PMC: 11861896. DOI: 10.1038/s41598-025-91423-z.


Exploring TGF-β Signaling in Cancer Progression: Prospects and Therapeutic Strategies.

Sheikh K, Amjad M, Irfan M, Anjum S, Majeed T, Riaz M Onco Targets Ther. 2025; 18:233-262.

PMID: 39989503 PMC: 11846535. DOI: 10.2147/OTT.S493643.


Phosphorylation of FOXN3 by NEK6 promotes pulmonary fibrosis through Smad signaling.

Yu J, Li Y, Li Y, Liu X, Huo Q, Wu N Nat Commun. 2025; 16(1):1865.

PMID: 39984467 PMC: 11845461. DOI: 10.1038/s41467-025-56922-7.


MICAL1 Mediates TGF-β1-Induced Epithelial-to-Mesenchymal Transition and Metastasis of Hepatocellular Carcinoma by Activating Smad2/3.

Zhuang X, Wang C, Ge Z, Wu M, Chen M, Chen Z Cell Biochem Biophys. 2025; .

PMID: 39954154 DOI: 10.1007/s12013-025-01668-8.


References
1.
Aceto N, Bardia A, Miyamoto D, Donaldson M, Wittner B, Spencer J . Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014; 158(5):1110-1122. PMC: 4149753. DOI: 10.1016/j.cell.2014.07.013. View

2.
Ben-Haim N, Lu C, Guzman-Ayala M, Pescatore L, Mesnard D, Bischofberger M . The nodal precursor acting via activin receptors induces mesoderm by maintaining a source of its convertases and BMP4. Dev Cell. 2006; 11(3):313-23. DOI: 10.1016/j.devcel.2006.07.005. View

3.
Huang Y, Hu J, Chen F, Lecomte N, Basnet H, David C . ID1 Mediates Escape from TGFβ Tumor Suppression in Pancreatic Cancer. Cancer Discov. 2019; 10(1):142-157. PMC: 6954299. DOI: 10.1158/2159-8290.CD-19-0529. View

4.
David C, Massague J . Contextual determinants of TGFβ action in development, immunity and cancer. Nat Rev Mol Cell Biol. 2018; 19(7):419-435. PMC: 7457231. DOI: 10.1038/s41580-018-0007-0. View

5.
Shi Y, Hata A, Lo R, Massague J, Pavletich N . A structural basis for mutational inactivation of the tumour suppressor Smad4. Nature. 1997; 388(6637):87-93. DOI: 10.1038/40431. View